Theoretical risks are extrapolated from IGF-1 biology: Hypoglycemia : IGF-1 shares structural homology with insulin and can activate insulin receptors, particularly at high concentrations Growth factor signaling : Sustained IGF-1R activation carries theoretical oncogenic potential, as the IGF-1 axis promotes cell proliferation and survival Systemic effects : Reduced IGFBP binding means greater systemic exposure to active growth factor, potentially amplifying both therapeutic and adverse effects Organ-specific : Potential for cardiac hypertrophy and other tissue growth with chronic exposure MGF Side Effects# MGF safety data are limited to preclinical observations: Rapid clearance : The very short half-life limits systemic exposure, which may reduce off-target effects Local action : Endogenous MGF acts primarily as a local paracrine factor, suggesting that targeted administration may have a favorable safety profile No human data : Without clinical trials, the safety profile in humans remains undefined Proliferative concerns : As a satellite cell activator, theoretical concerns exist regarding uncontrolled proliferation, though preclinical data have not demonstrated this Dosing and Administration Comparison# IGF-1 LR3 Dosing# MGF Dosing# The short half-life of native MGF is a significant practical limitation
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
SdaA was reported to be the gene encoding either the structural gene of L-SD that catalyzes the deamination of serine to pyruvate or a positive activator of transcription [31]
Yes, it's safe during pregnancy at recommended doses
By enhancing the body's natural detoxification mechanisms, it promotes a more efficient and thorough detoxification process
The study was conducted in Croatia, a country with habitual low Se intake
In our option, vitamin C is best employed as at serum formulation (15% L-ascorbic acid + ferulic acid), in addition to oral supplementation